- Home
- NMRA vs JRS Comparison
NMRA vs JRS Comparison
Compare NMRA & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- JRS
- Stock Information
- Founded
- NMRA 2019
- JRS 2001
- Country
- NMRA United States
- JRS United States
- Employees
- NMRA N/A
- JRS N/A
- Industry
- NMRA
- JRS Finance/Investors Services
- Sector
- NMRA
- JRS Finance
- Exchange
- NMRA Nasdaq
- JRS Nasdaq
- Market Cap
- NMRA 268.5M
- JRS 224.5M
- IPO Year
- NMRA 2023
- JRS N/A
- Fundamental
- Price
- NMRA $1.62
- JRS $8.37
- Analyst Decision
- NMRA Buy
- JRS
- Analyst Count
- NMRA 8
- JRS 0
- Target Price
- NMRA $7.14
- JRS N/A
- AVG Volume (30 Days)
- NMRA 383.3K
- JRS 86.6K
- Earning Date
- NMRA 11-11-2025
- JRS 01-01-0001
- Dividend Yield
- NMRA N/A
- JRS 8.87%
- EPS Growth
- NMRA N/A
- JRS N/A
- EPS
- NMRA N/A
- JRS N/A
- Revenue
- NMRA N/A
- JRS N/A
- Revenue This Year
- NMRA N/A
- JRS N/A
- Revenue Next Year
- NMRA N/A
- JRS N/A
- P/E Ratio
- NMRA N/A
- JRS N/A
- Revenue Growth
- NMRA N/A
- JRS N/A
- 52 Week Low
- NMRA $0.61
- JRS $5.95
- 52 Week High
- NMRA $17.19
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- NMRA 47.71
- JRS 75.10
- Support Level
- NMRA $1.60
- JRS $7.96
- Resistance Level
- NMRA $1.70
- JRS $8.21
- Average True Range (ATR)
- NMRA 0.09
- JRS 0.08
- MACD
- NMRA -0.01
- JRS 0.03
- Stochastic Oscillator
- NMRA 8.51
- JRS 96.51
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.